We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Removal of RNA Molecule Shown to Suppress Cancer Growth

By LabMedica International staff writers
Posted on 14 Jun 2011
New research demonstrated that the removal of a RNA molecule in mice could suppress carcinogenic tumor formation.

The study's findings were published in the journal Proceedings of the [US] National Academy of Sciences' early edition online in June 2011. Yong Li, PhD, associate professor of biochemistry and molecular biology at the University of Louisville (KY, USA) and his research team led by postdoctoral fellows Drs. Xiaodong Ma and Munish Kumar found that the removal of a noncoding RNA molecule known as microRNA 21 (miR-21) suppressed the formation of skin tumors in mice. This molecule was targeted for research because of its presence in human cancer formation, according to Dr. Li. "In virtually all types of cancer, miR-21 is found to be present at elevated levels," Dr. Li noted. "We believe it is essential to the growth of cancers."

Two groups of mice--18 with miR-21 removed and a control group of 23 with miR-21 intact--were evaluated after skin tumors known as papillomas were induced with a heavy dose of a carcinogen. The group without miR-21 had just 1.5 tumors per mouse after 30 weeks, as compared to 2.5 tumors per mouse in the control group. Moreover, one of the mice without miR-21 was tumor-free at the end of the study.

"Our work leads us to believe that miR-21 ablation increases the body's own tumor suppressing ability to hold back tumors," Dr. Li said. "The cancer research community is increasingly aware the importance of the surroundings around tumor cells. Our ongoing study of miR-21 involves looking at how this molecule contributes to tumor environment."

"We began our work in 2008 with the hypothesis that miR-21 plays a role in cardiovascular disease and diabetes," Dr. Li said. "However, our research and reports from other groups suggest it does not, although we are continuing our work in these areas. Funding basic research is important because you never know where science will take you. It is clear from our research that miR-21 is taking us a bit closer to understanding tumor formation."

Related Links:

University of Louisville





New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test
New
Flu Test
ID NOW Influenza A & B 2

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries